These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29173108)

  • 21. Visual elements in direct-to-consumer advertising: Messages communicated to patients with arthritis.
    Willis E
    Health Mark Q; 2017; 34(1):1-17. PubMed ID: 28350274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consumer confusion between prescription drug precautions and side effects.
    Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC
    Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unintended consequences of argument dilution in direct-to-consumer drug advertisements.
    Sivanathan N; Kakkar H
    Nat Hum Behav; 2017 Nov; 1(11):797-802. PubMed ID: 31024121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in exposure to televised prescription drug advertising, 2003-2011.
    Kornfield R; Alexander GC; Qato DM; Kim Y; Hirsch JD; Emery SL
    Am J Prev Med; 2015 May; 48(5):575-9. PubMed ID: 25891057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease-specific direct-to-consumer advertising for reminding consumers to take medications.
    Bhutada NS; Rollins BL
    J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thinking outside the medicine cabinet: a comparative content analysis of direct-to-consumer advertisements for prescription drug treatments.
    McKeever R
    Health Mark Q; 2014; 31(4):353-69. PubMed ID: 25405635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers' attitudes and behaviors.
    Bhutada NS; Rollins BL
    Res Social Adm Pharm; 2015; 11(6):891-900. PubMed ID: 25797861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population.
    Bailey TA; Fenney M
    Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis.
    Aikin KJ; Sullivan HW; Dolina S; Lynch M; Squiers LB
    J Med Internet Res; 2017 Jul; 19(7):e225. PubMed ID: 28676469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Rollins BL
    Int J Health Policy Manag; 2016 Feb; 5(4):287-8. PubMed ID: 27239875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct-to-consumer prescription medication advertisements and obtaining prescriptions with or without a doctor's prescription.
    Fogel J; Zhuk A
    Health Mark Q; 2019; 36(3):220-235. PubMed ID: 31267822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Inconsistency Appeals on the Influence of Direct-to-Consumer Prescription Drug Advertisements: An Application of Goal Disruption Theory.
    Rosenberg BD; Siegel JT
    J Health Commun; 2016; 21(2):217-27. PubMed ID: 26716683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Media credibility and informativeness of direct-to-consumer prescription drug advertising.
    Huh J; DeLorme DE; Reid LN
    Health Mark Q; 2004; 21(3):27-61. PubMed ID: 15739826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements.
    Fahim G; Toscani M; Barone JA; Wang C; Gandhi S
    Ther Innov Regul Sci; 2018 Jan; 52(1):114-117. PubMed ID: 29714616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disclosing accelerated approval on direct-to-consumer prescription drug websites.
    Sullivan HW; O'Donoghue AC; David KT; Patel NJ
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.